INS and Insulin resistance: Prior to menopause, women typically exhibit elevated estrogen levels, which can enhance insulin sensitivity by activating the AMPK signaling pathway and reducing visceral fat accumulation, thereby decreasing the risk of insulin resistance (44, 45).